0 items USD 0.00Search
Your search for "chronic lymphoma leukemia" gave back 5200 results.
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at US$ 120.9 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at USD 127.2 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Chlorambucil, sold under the brand name Leukeran among others, is a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Bendamustine market size was valued at USD 815.2 million in 2023 and is forecast to a readjusted size of USD 767.3 million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Highlights The global CAR-T Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
